{"transactions":[{"id":3100773,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":148254,"kind":"person","name":"WILCOX GARY","position":1,"cik":"0001222257","reported_name":"WILCOX GARY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-24T22:12:33.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest as follows: 100,000 stock options will vest on the one year anniversary of the grant date and the remaining 100,000 stock options will vest in eight equal quarterly increments with the first such quarterly increment vesting on September 30, 2021."}],"balance_after":200000,"derivative":{"exercise_price":1.33,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-20-011748","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315220011748/ownership.xml","form_type":"4"}},{"id":3808999,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":148254,"kind":"person","name":"WILCOX GARY","position":1,"cik":"0001222257","reported_name":"WILCOX GARY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-09-24T13:00:34.000Z","date":"2018-09-21","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock options vest as follows: 1/4 will vest on the one year anniversary of the grant date and the remaining 3/4 will vest in 12 equal quarterly increments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options are intended to be incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Only $100,000 (or 35,971 options) may first become exercisable by the Reporting Person in each calendar year."}],"balance_after":200000,"derivative":{"exercise_price":2.78,"expiration_date":"2028-09-20","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-18-013623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315218013623/ownership.xml","form_type":"4"}},{"id":4610967,"issuer":{"id":7621,"kind":"organization","name":"Cocrystal Pharma, Inc."},"owners":[{"id":148254,"kind":"person","name":"WILCOX GARY","position":1,"cik":"0001222257","reported_name":"WILCOX GARY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"INTERIM CEO"}}],"security":"Common Stock","published_at":"2016-09-06T20:15:10.000Z","date":"2016-09-01","kind":"purchase","acquired":true,"shares":10000,"price":0.41,"value":4100.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":16948605,"source":{"system":"sec-edgar","filing":"0001415889-16-007050","document":"form4-09062016_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1412486/000141588916007050/form4-09062016_040901.xml","form_type":"4"}}]}